東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Circulating nucleic acids in early d...

Gahan, Peter B.

FindBook

Google Book

Amazon

博客來

Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring = an introduction /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring/ edited by Peter B. Gahan.
其他題名:	an introduction /
其他作者:	Gahan, Peter B.
出版者:	Dordrecht :Springer Netherlands : : 2015.,
面頁冊數:	xix, 471 p. :ill. (some col.), digital ;24 cm.
內容註:	Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4 Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.
Contained By:	Springer eBooks
標題:	Nucleic acids - Diagnostic use. -
電子資源:	http://dx.doi.org/10.1007/978-94-017-9168-7
ISBN:	9789401791687 (electronic bk.)

Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring = an introduction /
Circulating nucleic acids in early diagnosis, prognosis and treatment monitoringan introduction /[electronic resource] :edited by Peter B. Gahan. - Dordrecht :Springer Netherlands :2015. - xix, 471 p. :ill. (some col.), digital ;24 cm. - Advances in predictive, preventive and personalised medicine,v.52211-3495 ;. - Advances in predictive, preventive and personalised medicine ;v.1..

Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4 Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.

DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: Background and general biology of circulating nucleic acids Methodology Applications of circulating nucleic acids Quality Assurance Ethics

ISBN: 9789401791687 (electronic bk.)

Standard No.: 10.1007/978-94-017-9168-7doiSubjects--Topical Terms:

2132446
Nucleic acids
--Diagnostic use.

LC Class. No.: RB43.8.N83

Dewey Class. No.: 616.0756

Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring = an introduction /
LDR:02839nmm a2200325 a 4500 001 1993887
003 DE-He213
005 20150727135155.0
006 m d
007 cr nn 008maaau
008 151019s2015 ne s 0 eng d
020 $a 9789401791687 (electronic bk.)
020 $a 9789401791670 (paper)
024 7 $a 10.1007/978-94-017-9168-7 $2 doi
035 $a 978-94-017-9168-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RB43.8.N83
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
082 0 4 $a 616.0756 $2 23
090 $a RB43.8.N83 $b C578 2015
245 0 0 $a Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring $h [electronic resource] : $b an introduction / $c edited by Peter B. Gahan.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a xix, 471 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in predictive, preventive and personalised medicine, $x 2211-3495 ; $v v.5
505 0 $a Part I. BACKGROUND -- CHAPTER 1 Introduction - Brief History and the present and future status of CNAPS -- CHAPTER 2 The biology of CNAPS -- Part II. METHODOLOGY -- CHAPTER 3 Pre-analytical requirements for analysing nucleic acids from blood -- CHAPTER 4 Circulating DNA and miRNA isolation -- CHAPTER 5 Detection of genetic alterations by nucleic acid analysis: use of pcr and mass spectroscopy-based methods -- CHAPTER 6 Genomic approaches to the analysis of cell free nucleic acids -- Part III APPLICATIONS -- CHAPTER 7 CNAPS and General Medicine -- CHAPTER 8 Fetal CNAPS DNA/RNA -- CHAPTER 9 Circulating nucleic acids and Diabetes mellitus -- CHAPTER 10 Extracellular nucleic acids and cancer -- CHAPTER 11 Other bodily fluids as non-invasive sources of Cell-free DNA/RNA -- CHAPTER 12 CNAPS in therapy monitoring -- Part IV OTHER ASPECTCS -- CHAPTER 13 Quality Assurance -- CHAPTER 14 Societal Aspects: Ethics.
520 $a DNA and RNA fractions can be isolated from a variety of body fluids including whole blood, serum, plasma, urine, saliva and cerebrospinal fluid from both patients and healthy individuals. Such isolates can be exploited in the early detection of clinical disorders, stratification of patients for treatment, treatment monitoring and clinical follow-up. In addition, the use in fetal medicine allows the early detection of fetal sex, Rh factor and aneuploid disorders as well as following both fetal and premature born infant development. This volume is intended as a primer for those who are interested in entering the field of circulating nucleic acids. The areas covered in this volume include: Background and general biology of circulating nucleic acids Methodology Applications of circulating nucleic acids Quality Assurance Ethics
650 0 $a Nucleic acids $x Diagnostic use. $3 2132446
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Biomedicine general. $3 890966
650 2 4 $a Health Promotion and Disease Prevention. $3 894308
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Nucleic Acid Chemistry. $3 1243992
650 2 4 $a Medicinal Chemistry. $3 892420
700 1 $a Gahan, Peter B. $3 1530622
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in predictive, preventive and personalised medicine ; $v v.1. $3 1621245
856 4 0 $u http://dx.doi.org/10.1007/978-94-017-9168-7
950 $a Medicine (Springer-11650)